Tech Company Financing Transactions
Toragen Funding Round
Toragen, based in San Diego, scored $12 million from private investors and GenHenn Venture.
Transaction Overview
Company Name
Announced On
9/30/2025
Transaction Type
Debt
Amount
$12,000,000
Round
Undisclosed
Investors
private investors (Lead Investor) (Steven Lebow)
GenHenn Venture (Bill Hagaman)
Proceeds Purpose
This financing enables us to advance the next critical steps in developing TGN-S15, our lead candidate, and prepare for our upcoming clinical trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10210 Campus Point Dr. 150
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Undisclosed
Website
Email Address
Overview
Toragen, a San Diego, CA-based biotechnology company targeting the root cause of virally induced cancers. Our team is comprised of industry leaders with decades of experience in early stage biotechnology startups, translational drug development, and practice-changing Phase III clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sandra Coufal
Chief Financial Officer
Cheryl Collett
Founder
Andrew Sharabi
VP - R & D
Richard Lumpkin
Browse more venture capital transactions:
Prev: 9/30/2025: PostHog venture capital transaction
Next: 10/1/2025: Simplifya venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs